GB953250A - Pharmaceutical compositions comprising diphospho-pyridine nucleotide or a derivative thereof - Google Patents

Pharmaceutical compositions comprising diphospho-pyridine nucleotide or a derivative thereof

Info

Publication number
GB953250A
GB953250A GB6794/62A GB679462A GB953250A GB 953250 A GB953250 A GB 953250A GB 6794/62 A GB6794/62 A GB 6794/62A GB 679462 A GB679462 A GB 679462A GB 953250 A GB953250 A GB 953250A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
diphospho
derivative
pyridine nucleotide
diphosphopyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6794/62A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PAUL FRANCIS O HOLLAREN
Original Assignee
PAUL FRANCIS O HOLLAREN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PAUL FRANCIS O HOLLAREN filed Critical PAUL FRANCIS O HOLLAREN
Publication of GB953250A publication Critical patent/GB953250A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Pharmaceutical compositions useful in the treatment of alcoholism comprise diphosphopyridine nucleotide or reduced diphosphopyridine nucliotide. They may be in solid unit dosage forms e.g. a tablet or capsule comprising from 100 to 1000 mg. of the active material and a solid carrier, in compositions for intravenous infusion comprising 50-1000 mg. dissolved in 100 ml. of aqueous isotonic saline or in forms suitable for rectal or intramuscular administration.
GB6794/62A 1961-03-02 1962-02-21 Pharmaceutical compositions comprising diphospho-pyridine nucleotide or a derivative thereof Expired GB953250A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9275661A 1961-03-02 1961-03-02

Publications (1)

Publication Number Publication Date
GB953250A true GB953250A (en) 1964-03-25

Family

ID=22234985

Family Applications (1)

Application Number Title Priority Date Filing Date
GB6794/62A Expired GB953250A (en) 1961-03-02 1962-02-21 Pharmaceutical compositions comprising diphospho-pyridine nucleotide or a derivative thereof

Country Status (3)

Country Link
ES (1) ES274849A1 (en)
FR (1) FR1929M (en)
GB (1) GB953250A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109364095A (en) * 2018-10-15 2019-02-22 河南省锐达医药科技有限公司 Oxidation state nicotinamide adenine dinucleotide NAD+Alleviate people in treatment to drink the application of process ethylism symptom

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109364095A (en) * 2018-10-15 2019-02-22 河南省锐达医药科技有限公司 Oxidation state nicotinamide adenine dinucleotide NAD+Alleviate people in treatment to drink the application of process ethylism symptom

Also Published As

Publication number Publication date
FR1929M (en) 1963-07-22
ES274849A1 (en) 1962-06-16

Similar Documents

Publication Publication Date Title
JPS57212114A (en) Capsule containing allergen activator and preparation therefor
Tillander et al. EXCRETION RATE OF METHYL MERCURY IN THE SEAL(PUSA HISPIDA)
IL34713A (en) Anaesthetic pharmaceutical preparations containing 3alpha-hydroxy-5alpha-pregnane 11,20-dione
NL161434C (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ALFA-SYMPATHICOLYTIC ACTION, FORMED PREPARATIONS AND PROCESS FOR THE PREPARATION OF AMINOALKYL TETRAHYDRO 1-KETONE AFTALENE DERIVATIVES.
GB953250A (en) Pharmaceutical compositions comprising diphospho-pyridine nucleotide or a derivative thereof
GB1270049A (en) New pharmaceutical product
BE622943A (en) Therapeutic compositions, containing emetine derivatives.
GB1049996A (en) New medicine with anti-inflammatory and anti-rheumatic activity
ES294897A1 (en) Improvements introduced in the preparation of pharmaceutical compositions in the form of unit dose (Machine-translation by Google Translate, not legally binding)
GB950162A (en) Medicines for the treatment of hepatic disorders
GB914512A (en) Novel therapeutic compositions
GB931921A (en) Therapeutic compositions intended for the treatment of any hepatic malfunctionings
GB911179A (en) Hypnotic and tranquilizing compositions comprising 4, 6-dimethyl-3-pyridazone
GB828766A (en) Medicine for reducing cholesterol level of the blood
GB1008178A (en) Compositions containing nucleoside derivatives for treating coronary affections
NL154217B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS IN WHICH ONE PUTS 11-ALKOXY-3-KETOSTEROIDS WITH AN OXYGEN FUNCTION IN THE 17-PLACE IN MEDICAL USE FORM OF ADMINISTRATION, THE PREPARED MEDICINAL PRODUCTS, AS PREPARED MEDICINAL PRODUCTS, AS PREPARED PREPARATIONS.
GB892784A (en) Pharmaceutical compositions comprising 3-pyridine acetic acid
Thomas et al. Restoration of marrow function after lethal doses of thio-tepa by infusion of isogenic marrow
GB891445A (en) Pharmaceutical compositions comprising sulphonamido-thiadiazole derivatives
GB976096A (en) Pharmaceutical compositions
FR1777M (en) Medicinal product containing preparations for hypertension.
GB1120964A (en) Pharmaceutical compositions containing glycol polymers
ES276322A1 (en) Method for the treatment of the affection of drugs (Machine-translation by Google Translate, not legally binding)
BE617615A (en) Novel octahydrophenanthrenoic acids, pharmaceutical compositions containing them and their preparation.
FR1210456A (en) Projectile for administering drugs to animals